Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA), a novel anti-infective agent with the potential to address neglected tropical diseases.
Life Sciences BC announced that Phyton Biotech was included in its list of 2025 LSBC Companies to Watch as part of its 27th Annual Life Sciences BC Awards. This recognition highlights outstanding companies to take note of and watch in the life sciences and biotech sectors.
Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound.
Phyton Biotech LLC. proudly announces a significant milestone in its journey toward advancing pharmaceutical research and development.
Phyton Biotech is delighted to be attending BIO-Europe in Munich from November 6th to 8th, 2023.
Phyton Biotech to attend CPhI Europe in Barcelona from October 24-26, 2023
Phyton Biotech to attend BioJapan from October 11 to 13, 2023
Phyton Biotech to attend CPhI China in Shanghai from June 19 to 21, 2023
Phyton Biotech is delighted to be attending the 1st International Cellular Agriculture conference in Helsinki from June 14 to 15, 2023.
From April 19-21, Phyton Biotech will be at CPhI Japan in Tokyo to discuss its speciality fermentation capabilities with Pharmaceutical Industry representatives.
ABSTRACT for Society of Economic Botany Conference, June 4-9, 2023: Sustainable Production of Natural Substances by Plant Cell Cultivation, Gilbert Gorr, Phyton Biotech GmbH
On International Women’s Day, Phyton Biotech recognizes all the women in the field of Medical Science and Technology.
This June, Phyton Biotech is a sponsor of the upcoming Economic Botany 2023 Conference.
This November, Phyton Biotech will be at stand 121A50 at CPhI Worldwide 2022 in Frankfurt.
Dr. Marisol Ochoa-Villareal joins Phyton Biotech's R&D Team in Germany.
Phyton Biotech is pleased to announce organizational changes at Phyton Biotech in Germany.
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech will showcase its specialty fermentation solutions at CPhI Worldwide online and in-person, this October and November.
Phyton Biotech is pleased to announce approval from China’s regulatory body – National Medical Products Administration (NMPA) - for Phyton’s Drug Master File for paclitaxel active pharmaceutical ingredient produced via plant cell fermentation (PCF®).
